CVS Health Price Prediction

CVS Health Corporation -- USA Stock  

USD 65.86  0.75  1.13%

Macroaxis is not in business of monitoring CVS Health headlines and social sentiment data; there are plenty of companies out there that do it quite successfully. However, we do analyze noise-free headlines and recent hype associated with CVS Health Corporation brand which may create opportunities for some arbitrage if properly timed. With CVS Health hype-based prediction module you can estimate the value of CVS Health Corporation from the prospective of CVS Health response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on CVS Health over a specific investment horizon. Check also CVS Health Basic Forecasting Models to cross-verify your projections.
 Time Horizon     30 Days    Login   to change

CVS Health After-Hype Price Density Analysis

 Next price density 
 
Expected price to next headline

CVS Health Estimiated After-Hype Price Volatility

April 19, 2018
65.86
Current Value
65.94
After-hype Price
Target Price Odds
 Above  Below  
70.71
Upside
CVS Health is not too risky asset. Analysis and calculation of next after-hype price of CVS Health is based on 2 months time horizon.

CVS Health Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.15% 1.59% 0.08%  0.07% 2 Events / Month4 Events / MonthIn a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
65.8665.940.12%
318.00% 

CVS Health Hype Timeline

On 19 of April CVS Health Corporation is traded for 65.86. This company has historical hype elasticity of 0.08 and average elasticity to hype of competition of 0.07. CVS Health Corporation is estimated to increase in value after the next headline with price going to jump to 65.94. The average volatility of media hype impact on the company stock price is about 318.0%. The price escalation on the next news is estimated to be 0.12% where as daily expected return is currently at -0.15%. The volatility of related hype on CVS Health is about 359.8% with expected price after next announcement by competition of 65.93. The company reported last year revenue of 184.77 B. Total Income to common stockholders was 6.61 B with profit before taxes, overhead, and interest of 28.55 B. Considering 30-days investment horizon, the next estimated press release will be in a few days.
Check also CVS Health Basic Forecasting Models to cross-verify your projections.

CVS Health Related Hype Analysis

Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
Laboratory Corporation of America Holdings(0.50) 3 per month 0.00 (0.0409)  1.71 (1.94)  4.48 
MEDNAX(0.02) 3 per month 0.00 (0.12)  1.81 (2.18)  5.14 
Envision Healthcare Corporation 0.03 2 per month 3.06  0.0192  3.80 (2.85)  12.54 
Concord Medical Services Holdings Limited(0.0009) 1 per month 2.31  0.20  7.09 (4.15)  17.75 
Centene Corporation 5.61 3 per month 0.93  0.18  2.39 (1.88)  8.38 
CVS Health Corporation 0.50 2 per month 0.00 (0.0741)  2.72 (1.98)  5.46 
Community Health Systems(0.14) 2 per month 0.00 (0.13)  5.06 (9.84)  23.89 
DaVita(0.36) 3 per month 0.00 (0.24)  1.54 (2.86)  5.33 
HCA Healthcare(0.70) 3 per month 0.00 (0.0301)  1.54 (2.01)  4.00 
Encompass Health Corporation 0.00 0 per month 5.01  0.15  0.20 (0.20)  9,032 

Contributor Headline

Latest Prospective on CVS Health

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check also CVS Health Basic Forecasting Models to cross-verify your projections. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.